Christopher Milkie, DPM
Podiatrist · Wauwatosa, WINPI 1013014166
Payments from drug & device makers
What this record shows
This record is dominated by entertainment: $377 of the $544 with a category attached, or 69.3%. Musculoskeletal Transplant Foundation Inc. accounts for 69.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $392 and has fallen 93.1% since, to $27 in 2023. That places this record below the midpoint for podiatrist clinicians in WI, where the typical reported total is $1,012.
Across 7 payments — averaging $77.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$377
- Orthofix Medical, Inc.$78
- Stryker$27
- Smith+Nephew$24
- Bioventus LLC$22
- Integra Lifesciences Corporation$16
Across 5 payments — averaging $7406.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$33K
- Bristol Myers Squibb$4K
What the payments were for
- Food & beverage$16731%
- Entertainment$37769%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 1 | $377 |
| Orthofix Medical, Inc. | 2 | $78 |
| Stryker | 1 | $27 |
| Smith+Nephew | 1 | $24 |
| Bioventus LLC | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $16 |
How this compares
$544 in reported general payments places this provider in the 40th percentile of 140 podiatrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 16 | $460 |
| Terbinafine Hcl | 20 | $410 |
| Doxycycline Hyclate | 32 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $230 |
| Meloxicam | 15 | $30 |
| Prednisone | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Wauwatosa
- Zachary BethWauwatosa$6K
- Bradley Abichtla Crosse$308K
- Scott Carringtonla Crosse$116K
- Jason DevriesManitowoc$31K
- Randall DeiFranklin$20K
- Jacob HagenbucherMadison$13K
- Andrea CifaldiEau Claire$13K
- Jonathan ShihFranklin$11K
- Naren PatelMadison$10K
- Brandon ScharerGreen Bay$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.